Latest News

Attune Medical Major Milestones: Including ensoETM in Cardiac Ablation Procedures Published Study and $4 Mil Convertible Note Closing

Dr. Mark Gallagher (St. George’s University Hospital, London UK) evaluated the use of the ensoETM in cardiac ablation procedures to ascertain whether using the esophageal space for temperature management could have the potential to decrease collateral thermal injury related to radio-frequency (RF) ablation for the treatment of atrial fibrillation.

Signia Introduces World’s First ‘Face Mask Mode’ for Hearing Devices: Improves Audibility for Those Communicating with Someone Wearing a Face Covering & No More Lip Reading

“The hearing challenges presented by face masks became obvious pretty quickly into the pandemic, so Signia developed the first-of-its-kind Face Mask Mode to help those with hearing loss better communicate in this new reality,” said Tish Ramirez, Au.D. of Signia. “When this setting is activated, the hearing aids optimally capture the sound of the speech signals, enabling the words to sound clearer and reducing any background noise to help the wearer understand what is being said.” 

Modulim Announces CE Mark of Clarifi Imaging System for Microvascular Assessment

Modulim can now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.

Genius AI Detection Receives FDA Clearance

Hologic notes the new technology which the company has now made commercially available represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius 3D Mammography exam.

New Bill Would Help Address Racial and Ethnic Disparities in Colorectal Cancer Care

April 2, 2019

New Bill: Colorectal cancer care advocates, minority health care organizations and medical associations want Congress to help address racial and ethnic disparities in screening and outcomes by passing the CT Colonography Screening for Colorectal Cancer Act (H.R. 1969).

The bipartisan bill introduced in the U.S. House of Representatives today by Reps. Danny Davis (D-IL) and Brad Wenstrup (R-OH) would provide Medicare coverage for CT Colonography (CTC) screening — also known as virtual colonoscopy.

Latino Americans  are more likely to die from colorectal cancer than those in many Central and South American countries. African Americans  are far more likely to die from the disease than whites.

U.S. Census Bureau National Health Interview Survey (NHIS) data shows that while virtual colonoscopy use is comparatively modest, largely due to lack of Medicare coverage, its use is growing more quickly among Latinos and African-Americans. Those in both groups are more likely than whites to choose virtual colonoscopy. However, at present, both groups are less likely to be screened for colorectal cancer and their cancers are found at a later stage than in whites.

“Latinos are less likely to get tested for colorectal cancer due to the fear associated with colonoscopy screenings, among other factors. Latinos are also more likely to die from the disease. Virtual colonoscopy is a safe alternative, and will lead more Latino seniors to get screened,” said Jose Ortiz, president and chief executive officer (CEO) of the Hispanic Health Council.

“Providing affordable options to patients is important. CT colonoscopy does not require sedation and is a screening option that many seniors need to consider. We can’t let this lack of Medicare coverage, or other unexpected costs, remain and inhibit seniors’ access to a lifesaving screening exam,” said Anjee Davis, president of Fight Colorectal Cancer.

“Colorectal cancer is largely preventable thanks to effective screening tools. Ensuring access to proven screening exams through Medicare is especially important for America’s vulnerable populations,” noted Rep. Davis.

Previous studies in the U.S. and abroad have shown that use of this American Cancer Society-recommended exam raises screening rates and lowers costs. Virtual colonoscopy is also supported by the U.S. Preventive Services Task Force as a colorectal cancer screening test.

“Timely screening for colorectal cancer can literally save lives, but many patients cannot or will not have a colonoscopy. For them, CT colonography provides a less invasive option that they are more likely to choose. Medicare should cover this screening option,” said Michael Sapienza, president and CEO of the Colorectal Cancer Alliance.

“Medicare-covered access to virtual colonoscopy can attract many who would otherwise not be tested, allowing doctors to remove polyps before they become cancers and prevent this deadly disease,” said Carolyn R. (“Bo”) Aldigé, CEO and founder of the Prevent Cancer Foundation.

Virtual colonoscopy is as accurate as standard colonoscopy in most people — including those 65 and older —and is far less invasive. Former President Obama had this test. Yet, Medicare refuses to cover seniors for these exams.

“Medicare coverage for virtual colonoscopy would ensure that the privately insured do not lose coverage for an exam they may want once they turn 65,” said Anne Carlson, president of the Colon Cancer Coalition.

“Medicare coverage of virtual colonoscopy can increase screening, help doctors find more cancers early and avoid cancers by removing polyps before they turn cancerous. This will save lives — particularly among those where screening rates are historically lower and outcomes not as good,” said Judy Yee, MD, chair of the American College of Radiology Colon Cancer Committee.

“As a doctor, I know how important cancer screenings are to detecting and treating disease as early as possible. That’s why I am again leading efforts to increase access for Medicare beneficiaries to get simple, essential colorectal cancer screenings,” said Rep. Wenstrup.

Nearly 40 states require insurance policies to cover virtual colonoscopy. Insurers who take part in federal exchanges are required by the Affordable Care Act (ACA) to cover the exam with no copay. UnitedHealthcare, CIGNA, Aetna, Anthem Blue Cross Blue Shield and others cover the test irrespective of ACA requirements.

Find more information on virtual colonoscopy (CT colonography) in English and Spanish at RadiologyInfo.org/virtualct.

Latest Posts

Fusion Antibodies and Queen’s University Belfast Awarded a £453,000 Grant from Invest Northern Ireland

The two organisations will use the funds to accelerate the discovery of novel therapeutic and diagnostic antibodies with validated anti-infective properties against COVID-19. Building on strong scientific knowhow, a new antibody development platform will be created that will help realise the vision of producing a breakthrough therapeutic that directly targets SARS-CoV-2.

Attune Medical Major Milestones: Including ensoETM in Cardiac Ablation Procedures Published Study and $4 Mil Convertible Note Closing

Dr. Mark Gallagher (St. George’s University Hospital, London UK) evaluated the use of the ensoETM in cardiac ablation procedures to ascertain whether using the esophageal space for temperature management could have the potential to decrease collateral thermal injury related to radio-frequency (RF) ablation for the treatment of atrial fibrillation.

Signia Introduces World’s First ‘Face Mask Mode’ for Hearing Devices: Improves Audibility for Those Communicating with Someone Wearing a Face Covering & No More Lip Reading

“The hearing challenges presented by face masks became obvious pretty quickly into the pandemic, so Signia developed the first-of-its-kind Face Mask Mode to help those with hearing loss better communicate in this new reality,” said Tish Ramirez, Au.D. of Signia. “When this setting is activated, the hearing aids optimally capture the sound of the speech signals, enabling the words to sound clearer and reducing any background noise to help the wearer understand what is being said.” 

Kayentis, a global provider of digital data capture systems for clinical trials, today announces it has raised €7M (approx. $8.3M) in growth capital.

Kayentis is active in the global electronic Clinical Outcome Assessment (eCOA) market, which is expected to reach $2.6 billion by 2027. Market growth in eCOA – a method of capturing outcomes data electronically in clinical trials – is driven by the clinical trials industry.

Don't Miss

New England Biolabs® Introduces NEBNext® Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set for Customizable RNA Depletion

This technology has been superb for eliminating the ribosomal RNA for a range of custom projects, including tracking novel viruses in mosquitoes, longitudinal profiling for astronauts, and host-pathogen interactions in COVID samples.

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

"FDA approval of the INTERCEPT Blood System for Cryoprecipitation is an important step forward in our mission to establish pathogen reduction as the standard of care for transfused blood components globally," said William ‘Obi’ Greenman, Cerus’ president and chief executive officer.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials. 

Stoke Therapeutics Announces Proposed Public Offering

November 18, 2020 Stoke Therapeutics, Inc., a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein...